|
Neuroimaging criteria for diagnosing Parkinson's disease and manganese Parkinsonism (acquired hepatocerebral degeneration)
|
|
| Author:
|
MUKHLISA KHANOVA, YAKUTKHON MADJIDOVA, NODIRA AZIMOVA, SITORA INOYATOVA, KAMILA NASIRKHODJAEVA
|
| Abstract:
|
Over the past decades, the impact of imaging diagnostic methods on the clinical sciences has been significant.
Since the invention of computed tomography (CT) and magnetic resonance imaging (MRI), tremendous
progress has been made in medical imaging of the human body. Neuroimaging of patients with neurotoxicity of
heavy metals can be divided into two groups: morphological neuroimaging (visualization based on anatomical
data), including CT and MRI; functional neuroimaging (physiology-based imaging) such as magnetic resonance
spectroscopy (MRS), single-photon emission computed tomography (SPECT), positron emission tomography
(PET), diffusion-tensor imaging (DTI) and functional MRI (fMRI)
|
| Keyword:
|
Parkinson's disease, neuroimaging methods, MRI, MSCT, PET, manganese parkinsonism, acquired hepatocerebral degeneration, nonwilson degeneration, secondary parkinsonism+, heavy metals.
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2020.12.03.243
|
| Download:
|
Request For Article
|
|
|